Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
3
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
pfizer
president trump
3
×
raleigh-durham blog main
raleigh-durham top stories
roche
3
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
alzheimer's disease
amgen
biogen
cancer
cancer immunotherapy
deals
diagnostics
What
bio
drug
3
×
roundup
patients
plan
acquisitions
advantages
albert
alzheimer’s
bar
biggest
bourla
brings
ceo
companies
company
crispr
different
expect
fail
future
gamble
gene
imports
increases
latest
maker
maps
market
measured
medco’s
mover
new
payers
pfizer
pfizer’s
pharmaceutical
physicians
prescription
price
Language
unknown
unset
Current search:
roche
×
drug
×
" president trump "
×
medicare
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More